Johnson & Johnson

NYSE:JNJ  
170.18
+0.22 (+0.13%)
Mergers / Acquisitions

Johnson & Johnson Announces Advance Purchase Agreement With The African Vaccine Acquisition Trust For Co's Covid-19 Vaccine Candidate

Published: 03/29/2021 07:24 GMT
Johnson & Johnson (JNJ) - Johnson & Johnson Announces Advance Purchase Agreement With the African Vaccine Acquisition Trust for the Company's Covid-19 Vaccine Candidate.
Up to 400 Million Doses of Company's Single-shot Vaccine Candidate Will Be Made Available to African Union Member States.
Availability of Vaccine is Subject to National Regulatory Approvals.
Janssen Pharmaceutica Agreed With African Vaccine Acquisition Trust (avat) to Make Available Up to 220 Million Doses of Its Single-shot Covid-19 Vaccine.
Janssen Pharmaceutica Vaccine Will Be Available to African Union's 55 Member States With Delivery Beginning in Q3 of 2021.